v3.26.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash flows from operating activities:    
Net loss $ (40,591) $ (27,270)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization expense 49 43
Stock-based compensation expense 4,647 2,635
Net amortization of premiums and accretion of discounts on short-term investments (754) (1,735)
Non-cash lease expense 151 134
Changes in operating assets and liabilities:    
Accounts receivable (366) 47
Prepaid expenses and other assets (11,046) (13,745)
Accounts payable (1,016) 711
Accrued expenses and other current liabilities 1,229 (1,851)
Operating lease liabilities (155) (134)
Net cash used in operating activities (47,852) (41,165)
Cash flows from investing activities:    
Purchases of short-term investments (14,422) (266,056)
Maturities of short-term investments 56,822 52,675
Net cash provided by (used in) investing activities 42,400 (213,381)
Cash flows from financing activities:    
Payments of initial public offering costs 0 (34)
Proceeds from exercises of stock options 598 0
Net cash provided by (used in) financing activities 598 (34)
Net decrease in cash, cash equivalents and restricted cash (4,854) (254,580)
Cash, cash equivalents and restricted cash at beginning of period 101,772 326,086
Cash, cash equivalents and restricted cash at end of period 96,918 71,506
Cash, cash equivalents and restricted cash at end of period:    
Cash and cash equivalents 96,724 71,312
Restricted cash 194 194
Total cash, cash equivalents and restricted cash at end of period $ 96,918 $ 71,506